10th – 11th September 2024 | Suntec Singapore Convention & Exhibition Centre
The biopharmaceutical industry has witnessed a remarkable expansion, with the global biopharma Contract Manufacturing Organization (CMO) market soaring to USD 17.41 billion in 2023. This market is projected to reach a staggering USD 39.31 billion by 2031, demonstrating a robust Compound Annual Growth Rate (CAGR) of 10.72%. Concurrently, the Contract Development and Manufacturing Organization (CDMO) market is not far behind, standing at USD 15.32 billion in 2024 and anticipated to escalate to USD 27.94 billion by 2029, reflecting a CAGR of 12.78%.
While North America has been at the forefront of the CMO/CDMO industry, the Asia Pacific region is quickly emerging as a dynamic and rapidly expanding market. Expected to enjoy a regional CAGR of 8.94% from 2024 to 2029, this growth is driven by a burgeoning population and an escalating demand for biologic treatments. Factors such as significantly lower labor costs—up to 30% less in manufacturing sectors—and supportive government policies and regulatory environments are propelling this surge.
Set against this vibrant backdrop, the 3rd Biologics Contract Manufacturing Asia 2024 conference stands out as the definitive event solely dedicated to contract manufacturing within the Asia-Pacific biologics sector. Scheduled for the 10th to 11th of September 2024 at the Suntec Singapore Convention & Exhibition Centre, this premium event is poised to catalyze the growth of the biologics CMO industry in the region.
Why Attend?
- Networking Opportunities: Connect with industry leaders, innovators, and decision-makers from across the globe in an exclusive setting.
- Insightful Discussions: Engage in panel discussions and presentations that delve into the latest trends, challenges, and advancements in the biologics contract manufacturing field.
- Strategic Partnerships: Explore potential collaborations with academia, regulatory bodies, and other stakeholders to enhance your capabilities and reach.
- Market Insights: Gain a deeper understanding of the market dynamics, including detailed analyses of regional growth drivers and economic factors influencing the industry.
Who Should Attend?
- CMO and CDMO Executives: Discover cutting-edge technologies and innovative strategies to enhance your operational efficiency and competitive edge.
- Biopharma Companies: Evaluate and select the right partners to scale production and meet the increasing demand for biologics.
- Regulatory and Policy Makers: Understand the impact of current and forthcoming regulations on the contract manufacturing landscape.
- Academic Researchers: Share insights and foster collaborations that translate scientific research into industrial success.
Event Highlights
- Expert Keynotes: Hear from top thought leaders about the future directions and technological innovations in biologic drug manufacturing.
- Interactive Workshops: Participate in workshops led by experts that offer practical solutions and strategies to tackle industry-specific challenges.
- Exhibition Space: Experience first-hand the latest services and technologies from leading suppliers and service providers in the biopharma sector.
This gathering is not just a conference; it’s a pivotal arena where the future of biopharmaceutical manufacturing is shaped, offering unparalleled access to the knowledge and tools needed to thrive in this rapidly evolving landscape. Mark your calendars for this indispensable event that promises to be a cornerstone for the biologics CMO and CDMO industry in Asia. For more information visit: https://imapac.com/events/biologics-contract-manufacturing-asia/
